AG
MRNA icon

AIA Group’s Moderna MRNA Stock Holding History

AIA Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,300
Closed -$982K – 351
2025
Q4 		$982K Buy
33,300
+5,129
+18% +$139K 0.01% 253
2025
Q3 		$728K Sell
28,171
-4,019
-12% -$112K 0.01% 320
2025
Q2 		$888K Sell
32,190
-9,764
-23% -$257K 0.02% 235
2025
Q1 		$1.19M Sell
41,954
-5,686
-12% -$202K 0.03% 213
2024
Q4 		$1.98M Buy
47,640
+31,349
+192% +$1.5M 0.05% 155
2024
Q3 		$1.09M Buy
16,291
+1,765
+12% +$162K 0.03% 213
2024
Q2 		$1.72M Buy
14,526
+1,526
+12% +$193K 0.05% 166
2024
Q1 		$1.39M Sell
13,000
-1,264
-9% -$127K 0.05% 181
2023
Q4 		$1.42M Buy
14,264
+365
+3% +$30.7K 0.06% 156
2023
Q3 		$1.44M Buy
13,899
+2,361
+20% +$263K 0.07% 129
2023
Q2 		$1.4M Buy
11,538
+2,566
+29% +$342K 0.07% 136
2023
Q1 		$1.38M Buy
8,972
+4,780
+114% +$789K 0.07% 119
2022
Q4 		$753K Sell
4,192
-3,031
-42% -$496K 0.05% 169
2022
Q3 		$854K Sell
7,223
-1,268
-15% -$192K 0.06% 139
2022
Q2 		$1.21M Sell
8,491
-7,244
-46% -$1.04M 0.07% 132
2022
Q1 		$2.71M Buy
15,735
+8,620
+121% +$1.45M 0.12% 74
2021
Q4 		$1.81M Buy
7,115
+680
+11% +$199K 0.09% 103
2021
Q3 		$2.48M Buy
6,435
+3,984
+163% +$1.47M 0.14% 86
2021
Q2 		$769K Buy
+2,451
New +$438K 0.05% 131

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIA Group's MRNA Position: Q1 2026 in Review

AIA Group sold out of Moderna (MRNA) in Q1 2026, closing a stake of 33,300 shares — an estimated $982K sold.

AIA Group first reported a position in MRNA in Q2 2021 and held it in 19 quarters. The position peaked at $2.71M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • AIA Group reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • AIA Group sold 33,300 Moderna shares in Q1 2026, an estimated $982K.
  • AIA Group first reported a position in Moderna in Q2 2021 and held it in 19 quarters.
  • AIA Group's Moderna position peaked at $2.71M in Q1 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.